Threshold Pharmaceuticals, Inc.
Records under this name other than the patents Threshold Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Threshold Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,003,625 | Phosphoramidate alkylator prodrugs Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,552,048 | Phosphoramidate alkylator prodrugs for the treatment of cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,765,690 | Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy Formerly held In force · High confidence | In force | High confidence | |
| US 8,946,275 | Treatment of cancer using hypoxia activated prodrugs Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,131,683 | TH-302 solid forms and methods related thereto Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,654,876 | TH-302 solid forms and methods related thereto Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,507,210 | Kinase inhibitor prodrug for the treatment of cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,364,261 | DNA alkylating agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,829,437 | Nitrobenzyl derivatives of anti-cancer agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,760,130 | Predictive Biomarker for Hypoxia-Activated Prodrug Therapy Formerly held In force · High confidence | In force | High confidence |